Ultragenyx Pharmaceutical Inc. buy Jefferies Financial Group Inc.
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€53.50
Performance (%)
16.88%
Price
10.04.26
€19.70
Summary
This prediction is currently active. The prediction currently has a performance of 16.88%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.073% | 2.073% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Jefferies_Financial_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Jefferies Financial Group Inc. from $114.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat